DNA & Genetics Cosmo Surges 40% on Baldness Candidate’s Phase III DataBy adminDecember 8, 20250 Images of the scalps of two patients treated with the 5% formulation of Cosmo Pharmaceuticals’ androgenetic alopecia (AGA) candidate clascoterone—both…
